Keywords: Cancer stem cells, BBI608, BBI503

Dainippon Sumitomo to acquire Boston Biomedical

Article | 01 March 2012

Japanese drugmaker Dainippon Sumitomo Pharma (4506: JP) says it has reached an agreement for the acquisition of privately-held US biotech firm ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in